Zhanrong Li

Zhanrong Li


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2024 in Nano-Micro Letters
Verified
Journal Article
Open access
PDF file
DCDandan Chu
Dandan Chu
MZMengyang Zhao
Mengyang Zhao
Shisong RongShisong Rong
Shisong Rong
WJWonho Jhe
Wonho Jhe
XCXiaolu Cai
Xiaolu Cai
JLJingguo Li
Jingguo Li
Dry eye disease (DED) is a major ocular pathology worldwide, causing serious ocular discomfort and even visual impairment. The incidence of DED is gradually increasing with the high-frequency use of electronic products. Although inflammation is core cause of the DED vicious cycle, reactive oxygen species (ROS) play a pivotal role in the vicious cycle by regulating inflammation from upstream. Therefore, current therapies merely targeting inflammation show the failure of DED treatment. Here, a novel dual-atom nanozymes (DAN)-based eye drops are developed. The antioxidative DAN is successfully prepared by embedding Fe and Mn bimetallic single-atoms in N-doped carbon material and modifying it with a hydrophilic polymer. The in vitro and in vivo results demonstrate the DAN is endowed with superior biological activity in scavenging excessive ROS, inhibiting NLRP3 inflammasome activation, decreasing proinflammatory cytokines expression, and suppressing cell apoptosis. Consequently, the DAN effectively alleviate ocular inflammation, promote corneal epithelial repair, recover goblet cell density and tear secretion, thus breaking the DED vicious cycle. Our findings open an avenue to make the DAN as an intervention form to DED and ROS-mediated inflammatory diseases.

1 January 2022 in Carbohydrate Polymers
Verified
Journal Article
Closed access
LSLiuqi Shi
Liuqi Shi
ZLZhanrong Li
Zhanrong Li
ZLZhen Liang
Zhen Liang
JZJunjie Zhang
Junjie Zhang
RLRuixing Liu
Ruixing Liu
JLJingguo Li
Jingguo Li

1 June 2023 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
XGXingchen Geng
Xingchen Geng
YWYiwei Wang
Yiwei Wang
HCHaohao Cui
Haohao Cui
CLChengcheng Li
Chengcheng Li
BCBoyuan Cheng
Boyuan Cheng
ZLZhanrong Li
Zhanrong Li

1 March 2023 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
RLRuixing Liu
Ruixing Liu
JLJingguo Li
Jingguo Li
ZGZhihua Guo
Zhihua Guo
DCDandan Chu
Dandan Chu
CLChengcheng Li
Chengcheng Li
ZLZhanrong Li
Zhanrong Li
Purpose: The purpose of this study was to investigate the effect of celastrol (CEL) on corneal stromal fibrosis after Descemet stripping endothelial keratoplasty (DSEK) and its associated mechanism. Methods: Rabbit corneal fibroblasts (RCFs) were isolated, cultured, and identified. A CEL-loaded positive nanomedicine (CPNM) was developed to enhance corneal penetration. CCK-8 and scratch assays were performed to evaluate cytotoxicity and the effects of CEL on the migration of RCFs. The RCFs were activated by TGF-β1 with or without CEL treatment, and then the protein expression levels of TGFβRII, Smad2/3, YAP, TAZ, TEAD1, α-SMA, TGF-β1, FN, and COLI were assessed by immunofluorescence or Western blotting (WB). An in vivo DSEK model was established in New Zealand White rabbits. The corneas were stained using H&E, YAP, TAZ, TGF-β1, Smad2/3, TGFβRII, Masson, and COLI. H&E staining of the eyeball was performed to assess the tissue toxicity of CEL at 8 weeks after DSEK. Results: In vitro CEL treatment inhibited the proliferation and migration of RCFs induced by TGF-β1. Immunofluorescence and WB showed that CEL significantly inhibited the protein expression of TGF-β1, Smad2/3, YAP, TAZ, TEAD1, α-SMA, TGF-βRII, FN, and COL1 induced by TGF-β1 in RCFs. In the rabbit DSEK model, CEL significantly reduced the levels of YAP, TAZ, TGF-β1, Smad2/3, TGFβRII, and collagen. No obvious tissue toxicity was observed in the CPNM group. Conclusions: CEL effectively inhibited corneal stromal fibrosis after DSEK. The TGF-β1/Smad2/3-YAP/TAZ pathway may be involved in the mechanism by which CEL alleviates corneal fibrosis. The CPNM is a safe and effective treatment strategy for corneal stromal fibrosis after DSEK.

1 November 2019 in Journal of Biomedical Nanotechnology
Verified
Journal Article
Closed access
ZLZhanrong Li
Zhanrong Li
DCDandan Chu
Dandan Chu
GCGenxin Chen
Genxin Chen
LSLiuqi Shi
Liuqi Shi
LJLin Jin
Lin Jin
JLJingguo Li
Jingguo Li
Fibrous scaffold could provide extracellular matrix (ECM) like structure and desired network for cell growth; however, the mechanical performance of this type uni-structured fibrous scaffold cannot meet the requirement of tissue formation. Therefore, new strategies are needed for form mechanical strength enhancement. In this study, we developed three dimensional double-network structured fibrous scaffold (3D DN-Fs) using self-assembly technology combined with electrospinning technology. Our 3D DN-Fs consists of two types of skeletons: the finer silk nanofibers which can mimic biocompatible ECM structure; and the larger skeletal fibrous layers can greatly improve the mechanical strength and cellular loading ability, and provide good nutrition and excreta delivery system for cell growth. Therefore, our 3D DN-Fs displayed excellent mechanical performance (more than 50% increment), biocompatibility, biodegradability, and a desirable microenvironment for cell growth. More importantly, cultured cells exhibited excellent viability and 3D growth. Our novel strategy greatly enhances the potential application of fibrous scaffold in the biomedical area, such as 3D cell culture and tissue engineering.

4 September 2020 in Frontiers in Chemistry
Verified
Journal Article
Open access
PDF file
HFHuayang Feng
Huayang Feng
DCDandan Chu
Dandan Chu
FYFan Yang
Fan Yang
ZLZhanrong Li
Zhanrong Li
BFBingbing Fan
Bingbing Fan
JLJingguo Li
Jingguo Li
Polymeric drug vectors have shown great potentials in cancer therapy. However, intelligent controlled release of drugs has become a major challenge in nanomedicine research. Hypoxia-responsive polymeric micelles have received widespread attention in recent years due to the inherent hypoxic state of tumor tissue. In this study, a novel diblock polymer consisting of polyethylene glycol and poly[glutamic acid (3-(2-nitro-imidazolyl)-propyl)] was synthesized and self-assembled into hypoxia-responsive polymeric micelles for the controlled release of doxorubicin (DOX). The cell experiments demonstrated that DOX-loaded micelles had a stronger killing capacity on tumor cells under hypoxic conditions, while the blank micelles had good biocompatibility. All the experiments indicate that our hypoxia-responsive polymeric micelles have a great potential for enhanced cancer treatment.